PTGS2 and bacterial infectious disease: Thus, in the current study, we utilised the DHPS inhibiting properties of sulphonamides and the COX-2 inhibiting properties of salicylamides as well as their beneficial antibacterial effects to provide a monotherapy approach targeting COX-2 and DHPS enzymes being effective against bacterial infections together with their sequential inflammatory actions with lower evidence of resistance.